Primo Chemicals Board Approves Cost Auditor Re-appointment and Scheme of Amalgamation for Flow Tech
Primo Chemicals' Board approved the re-appointment of M/s Kabra & Associates as Cost Auditor for FY 2026-27. The 51st AGM will be held on September 30, 2026. In-principle approval was given for the amalgamation of Flow Tech Chemical Private Limited with Primo Chemicals, subject to acquisition of remaining 51% stake and regulatory approvals.
The potential amalgamation of Flow Tech Chemical Private Limited into Primo Chemicals Limited is a significant strategic move that could lead to structural simplification and cost reductions. The re-appointment of the cost auditor and the scheduling of the AGM are routine corporate actions.
The announcement details routine re-appointments and procedural steps for a proposed amalgamation, which is a forward-looking step but does not immediately impact financials. The sentiment is neutral as it is a mix of standard corporate actions and a proposed strategic move.
Primo Chemicals Limited announced the outcome of its Board Meeting held on 14th August 2026. The Board approved the re-appointment of M/s Kabra & Associates as the Cost Auditor for the financial year 2026-27. The 51st Annual General Meeting (AGM) is scheduled for 30th September 2026 at 14:00 hours via Video Conferencing. The Register of Members and Share Transfer Books will be closed from 24th September 2026 to 30th September 2026 for the AGM.
Furthermore, the Board granted in-principle approval for the preparation of a Scheme of Amalgamation of Flow Tech Chemical Private Limited with Primo Chemicals Limited. This follows the shareholders' approval via postal ballot on 5th August 2026 for the acquisition of the remaining 51% shareholding in Flow Tech, which will make it a wholly owned subsidiary. The proposed amalgamation is expected to simplify the company structure, reduce compliance costs, and provide direct access to Flow Tech's operations. The amalgamation is conditional upon the completion of the acquisition of the remaining 51% stake in Flow Tech and will be subject to necessary approvals from regulatory bodies including the NCLT and stock exchanges.
The Board also authorized the internal management to take preparatory steps for the proposed Scheme of Amalgamation. M/s Kabra & Associates have been re-appointed as Cost Auditors for FY 2026-27.
What to do with a filing like this
Primo Chemicals Limited filed this with the NSE as a statutory disclosure, categorised under board meeting. It is a primary document, not a recommendation, and the desk marks it medium impact: worth reading, rarely worth acting on by itself.
That call is the part a filing cannot make for you. On RealCase, SEBI-registered research analysts and investment advisers read announcements like this one and turn the ones that matter into actions inside their model portfolios: a change in weight, a hold, or nothing at all. You are not left working out which of the roughly 250 filings published each day needs a response. The portfolio you follow is updated when a filing actually warrants it, with the reason written down.
See the model portfoliosA plain-language summary of a public exchange filing by Primo Chemicals Limited. Read the original for the full detail.